New Onset Diabetes After COVID 19 (NODAC) is predominantly due to exacerbated Insulin Resistance (IR) rather than beta cell dysfunction: Lessons from tertiary care hospital data during confluence of two epidemics
New onset diabetes after COVID-19 (NODAC)
"Patients with NODAC have evidence of persistent insulin resistance on follow up, underscoring the need for long term glycemic monitoring."